News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSante Pharmaceuticals, Inc. (BPA) Announces Subcontract With The University Of Nebraska-Lincoln


2/6/2006 11:11:31 AM

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Feb. 6, 2006--BioSante Pharmaceuticals, Inc. (AMEX:BPA) today announced that BioSante has been awarded a subcontract valued at $250,000 for the development of recombinant Factor IX (FIX) formulations for delivery via alternative routes of administration. The subcontract was awarded to BioSante by the University of Nebraska-Lincoln as part of their five year $10M grant entitled "cGMP Recombinant FIX for IV and Oral Hemophilia B Therapy" from the National Institutes of Health (NIH).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES